RE:RE:RE:RE:RE:ONCLOL
The way I am looking it this is, and the only way I can look at this is... as the warrants will die, there will be less dilution by the number of warrants, so my common shares will be worth more.... LOL
Just trying to keep it positive...haha
On another note, volume seems to have increased a bit into a declining SP.
Not sure who is selling.
I don't expect anything significant out of this June AGM, other than possibly that Bracelet is fully enrolled But think that will be a none event share price wise, but it does start the timer for top line data.
I think the Gastro data shoukd be a good NR in June/July out of Germany with Roche.
IMHO I keep thinkinh solid news there with a happy FDA could trigger a special protocol fast track Phase III for Gastro and move Gastro ahead of mBC as there is a big need in Gastro.
Speculation only, but thinking that could lead to a required partnership to jump into a Phase III gastro faster than the mBC.
Roche has been my fav for partnership or buyout for a long time and are the Gastro partner at this time. Just seems to make sense.
so will be interesting to see what we see though July Aug Sept in Gastro
Hoping with Enrollment completed for Bracelet we will start to see a slow climb til release of top line data.
China moving into a Phase III later this summer should also give SP a boost.
Still waiting....
Still watching....
but we are getting closer